Live Breaking News & Updates on Eua Application For Sputnikv Vaccine

Expert panel reviews EUA application for Sputnik V vaccine; seeks immunogenicity, safety data
India
Updated: Wednesday, February 24, 2021, 22:12 [IST]
New Delhi, Feb 24: An expert panel of India s Central Drug Authority which reviewed the application of Dr Reddy s Laboratories seeking emergency use authorisation for the COVID-19 vaccine Sputnik V on Wednesday recommended that the firm present immunogenicity and safety data, sources said.
Dr Reddy s Laboratories on February 19 said it had approached drugs regulator DCGI for emergency use authorisation (EUA) for the Russian vaccine.
The Subject Expert Committee (SEC) on COVID-19 of the CDSCO which discussed the application by Dr Reddy s Laboratories seeking emergency use authorisation for COVID-19 vaccine Sputnik V on Wednesday asked the firm to submit immunogenicity and safety data as per the protocol approved by the CDSCO. Once it submits these data, its EUA application will be considered, a source said. ....

Andhra Pradesh , New Delhi , Madhuri Adnal , Simran Kashyap , Gamaleya National Research Institute Of Epidemiology , Serum Institute Of India , Expert Committee , India Central Drug Authority , Ministry Of Health Russia On , Russian Direct Investment Fund , Central Drug Authority , Subject Expert Committee , Hyderabad Based Bharat Biotech , Drugs Controller General , Bharat Biotech , Serum Institute , Gamaleya National Research Institute , Breaking News , Instant Updates , Sputnikv Vaccine , Eua Application For Sputnikv Vaccine , Sputnikv Vaccine Data , Corona Vaccine , ஆந்திரா பிரதேஷ் , புதியது டெல்ஹி , சிம்ரன் காஷ்யப் ,